Why Technical Analysis Never Works

Let me point out a few harsh lessons learned from this most recent meltdown, and the rip-your-face-off rally that followed. Remember all those market gurus claiming stocks would rise every day for the rest of 2025? They were wrong. This is why almost every Trade Alert I shot out this year has been from the “RISK […]

The British Are Coming Back

In a market where biotech usually gets lumped into either “future cure” or “eternal underdog,” GSK (GSK) is carving out a third category: cash-flowing, specialty-driven, and still misunderstood. It’s not the hottest name in oncology. It’s not a dividend aristocrat either. But if you’re looking for where the next rerating in big pharma might come […]

How to Join the Early Retirement Stampede

There is a new social movement taking place that you probably haven’t heard about. Increasing numbers of people, especially Millennials, are engineering their personal finances to make early retirement possible. I’m not talking about hanging it up at 60, 55, or even 50. I’m talking extreme early retirement, like 45, 40, or even 30! I […]